RoslinCT is a contract manufacturing organisation focused on providing tailored process development services and robust GMP manufacturing solutions for companies developing cell-based therapeutics for clinical trials.
Supporting you at every step of your advanced therapy journey.
26 March 2019
RoslinCT is a leading Contract Development and Manufacturing Organisation (CDMO), offering a range of integrated services from technology transfer, process and assay development through to GMP manufacturing, storage, QP certification and batch release of cell-based therapies for clinical trials.
22 March 2019
RoslinCT, a leading cell and gene therapy contract manufacturing organisation, is pleased to announce the appointment of David Bowie to the Board of Directors. David has over twenty-eight years of international sales, marketing management and business development experience in the global healthcare sector which led him to the board of the Scottish Government backed Life Science Scotland Industry Leadership Group for some 12 years. David brings a wealth of life science industry experience, locally and globally, to the position.
18 October 2018
RoslinCT, a leading cell and gene therapy contract manufacturing organisation, is delighted to announce the appointment of Ian McCubbin OBE to the Board of Directors. Ian is a prominent figure within the Advanced Therapy community and brings a wealth of industry experience to the position
01:32 pm Jun 3rd
We are excited to have successfully completed our 3-year re-accreditation ISO 9001:2015 inspection this week. We ar… https://t.co/H7rbZp53sL
02:58 pm May 29th
At RoslinCT we care about what's important to you, that's why we always respect IP ownership. Find out more about u… https://t.co/BeMLvtUgxd
02:09 pm May 22nd
An exciting opportunity has arisen within our Quality team for an individual who shares our passion for quality. Fo… https://t.co/EB3Eq2nsJl